183540-47-8 Usage
Chemical Structure
A chemical compound consisting of ethanediol (a diol), a sulfonate group, a methoxymethoxyphenyl component (a derivative of phenyl and methoxy groups), and a stereochemistry of (1S)-.
Ethanediol
A diol functional group
Sulfonate
A sulfonate functional group
Methoxymethoxyphenyl
A phenyl ring with methoxy and methoxymethoxy groups
Chirality
The compound has a stereochemistry of (1S)-, indicating specific chirality properties.
Safety Considerations
It is important to handle 1,2-Ethanediol, 1-[3-(methoxymethoxy)phenyl]-,
2-(4-methylbenzenesulfonate), (1S)- with care and follow proper safety protocols due to its chemical structure and potential hazards.
Applications
The specific applications of 1,2-Ethanediol, 1-[3-(methoxymethoxy)phenyl]-,
2-(4-methylbenzenesulfonate), (1S)- are not provided in the material, but it may have potential uses in various industries such as pharmaceuticals, materials science, or chemical research.
Hazards
The material does not provide specific hazards associated with 1,2-Ethanediol, 1-[3-(methoxymethoxy)phenyl]-,
2-(4-methylbenzenesulfonate), (1S)-, but it is important to consider the potential hazards and safety considerations due to its chemical structure.
Storage
Proper storage conditions and handling procedures should be followed to ensure the safety and stability of the compound.
Purity
The purity of the compound is not provided in the material, but it is important to consider the purity when evaluating its properties and potential applications.
Solubility
The solubility of the compound is not provided in the material, but it may be influenced by the presence of the diol, sulfonate, and methoxymethoxyphenyl functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 183540-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,5,4 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 183540-47:
(8*1)+(7*8)+(6*3)+(5*5)+(4*4)+(3*0)+(2*4)+(1*7)=138
138 % 10 = 8
So 183540-47-8 is a valid CAS Registry Number.
183540-47-8Relevant academic research and scientific papers
Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
-
, (2008/06/13)
A compound of the following formula: and the salts thereof wherein A is hydrogen, halo, or hydroxy, broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1is optionally substituted phenyl; Ar2is aryl or heteroaryl selected from phenyl, napththyl, or pyridyl, the aryl or heteroaryl being optionally substituted; R1is hydrogen, hydroxy, or C1-C4alkyl; and R2and R3are independently selected from optionally substituted C1-C7alkyl, C3-C6cycloalkyl, C2-C6alkenyl, C2-C6alkynyl, or R2and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine. These compounds are useful as kappa agonists.
Pyrrolidinyl hydroxamic acid compounds and their production process
-
, (2008/06/13)
A compound of formula (I) STR1 and its pharmaceutically acceptable salt, wherein A is hydrogen or OY, wherein Y is a hydroxy protecting group; Ar is phenyl optionally substituted with one or more substituents selected from halo, hydroxy, C1 -C4 alkyl, C1 -C4 alkoxy, CF3, C1 -C4 alkoxy-C1 -C4 alkyloxy and carboxy-C1 -C4 alkyloxy; X is phenyl, naphthyl, biphenyl, indanyl, benzofuranyl, benzothiophenyl, 1-tetralone-6-yl,C1 -C4 alkylenedioxy, pyridyl, furyl and thienyl these groups optionally being substituted with up to three substituents selected from halo, C1 -C4 alkyl, C1 -C4 alkoxy, hydroxy, NO2, CF3 and SO2 CH3 ; and R is hydrogen, C1 -C4 alkyl or a hydroxy protecting group. These compounds and pharmaceutical compositions containing them are useful as analgesic, anti-inflammatory, diuretic, anesthetic or neuroprotective agents, or an agent for stroke or treatment of functional bowel diseases such as abdominal pain, for the treatment of a mammalian subject, especially a human subject. Further, the present invention provides processes for producing the hydroxamic compounds of formula (I) and their intermediate compounds of the formula. STR2
